Skip to main content
All lobbying filings

NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH

Lobbying for NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$30,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 5

Transportation of research animals

FY26/27 appropriations, support biomedical research language, NIH funding

Need for continued biomedical research with animal models, nonclinical testing, FY27 appropriations at HHS, USDA, FDA, NIH

Animal research advancing treatments and cures for humans and animals, appropriations

FY26/27 Appropriations, Permitting, Support for biomedical research, U.S. competitiveness, The Farm, Food, and National Security Act of 2026 H.R.7567, AFTER Act S.4172, FDA Modernization Act 3.0 H.R.2821, FY26 National Defense Authorization Act H.R.8800, importation of animals for research, COMPACT Act H.R.10522, BEAGLE Liberation Act H.R.10532, PUPPS Act H.R.10523

 Bills named in this filing 7

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem